Company / Inventory
ARS Pharmaceuticals, Inc. Inventory History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$31.4M
FY2025
5-year range
$0 / $31.4M
FY2023-FY2025
Trend
+198.7%
vs FY2024
Sector context
#69 of 105
Health Care
What the data says
At $31M, ARS Pharmaceuticals, Inc.'s inventory ranks #69 of 105 in the Health Care sector. Improved from $0 to $31M over the past 2 years.
Based on SEC 10-K filings.
$31M in FY2025.
Improved from $0 to $31M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#69 of 105 in Health CareTop 66% of 105This company $31.4M Sector average $885.3M
▼
-96.5% below sector average
Key checks
Key Insights
- In FY2025, inventory increased 198.7% year-over-year.
- Ranks #69 out of 105 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $31.4M | +198.7% |
| FY2024 | $10.5M | - |
| FY2023 | $0 | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026